CFPB Delays Effective Date for Medical Debt Advisory Opinion to January 2, 2025

Washington, D.C. — In significant development for the credit and collections industry, the Consumer Financial Protection Bureau (CFPB) has delayed its advisory opinion on medical debt effective to January 2, 2025. The decision follows an emergency motion filed by ACA International (ACA) as part of an ongoing lawsuit challenging the Bureau’s authority.

ACA, the largest association representing credit and collection professionals, argues that the CFPB’s advisory opinion represents regulatory overreach. According to the ACA, the CFPB failed to follow proper procedures outlined in the Administrative Procedure Act (APA) and has attempted to reinterpret the Fair Debt Collection Practices Act (FDCPA) — an action it believes exceeds the Bureau’s legal boundaries.

“The CFPB’s voluntary delay is a major win for ACA and its members,” said ACA CEO Scott Purcell. “We remain committed to ensuring that regulatory changes follow due process and stay within the bounds of the law.”

Why This Matters

This delay provides temporary relief to the credit and collections industry, giving stakeholders more time to prepare and respond as the legal challenge continues. It also underscores the ongoing tension between federal regulators and industry groups over how medical debt is treated under existing laws.

For more updates on how federal regulations like this impact consumers and debt professionals alike, visit **TalkinDebts.com** — your source for debt news, analysis, and insights.

About ACA International

Founded in 1939, ACA International represents a broad network of third-party collection agencies, law firms, asset buyers, creditors, and vendors. The organization offers compliance tools, education, and advocacy for tens of thousands of professionals in the credit and collections field. Learn more at www.acainternational.org.